Interleukin 8 secretion from monocytes of subjects heterozygous for the ΔF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 5, 2004, Pages 819-824

  Zaman, Munir M ^a   Gelrud, Andres ^a   Junaidi, Omer ^a   Regan, Meredith M ^a   Warny, Michel ^a   Shea, Julie C ^a   Kelly, Ciaran ^a   O'Sullivan, Brian P ^b   Freedman, Steven D ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b University of Massachusetts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CELL SURFACE RECEPTOR; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR 4; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ALLELE; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; ANTIGENS, CD14; CASE-CONTROL STUDIES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; HETEROZYGOTE; HUMANS; INTERLEUKIN-8; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; MUTATION; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 4644313798     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.5.819-824.2004     Document Type: Article

References (28)

1. Bonfield, T. L., M. W. Konstan, and M. Berger. 1999. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J. Allergy Clin. Immunol. 104:72-78.
2. Bonfield, T. L., J. R. Panuska, M. W. Konstan, K. A. Hilliard, J. B. Hilliard, B. Ghnaim, and M. Berger. 1995. Inflammatory cytokines in cystic fibrosis lungs. Am. J. Respir. Crit. Care Med. 152:2111-2118.
3. Casals, T., L. Bassas, S. Egozcue, M. D. Ramos, J. Gimenez, A. Segura, F. Garcia, M. Carrera, S. Larriba, J. Sarquella, and X. Estivill. 2000. Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. Hum. Reprod. 15:1476-1483.
4. Conn, J. A., K. J. Friedman, P. G. Noone, M. R. Knowles, L. M. Silverman, and P. S. Jowell. 1998. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N. Engl. J. Med. 339:653-658.
5. DiMango, E., A. J. Ratner, R. Bryan, S. Tabibi, and A. Prince. 1998. Activation of NF-κB by adherent Psuedomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J. Clin. Investig. 101:2598-2605.
6. Farrell, P. M., and R. E. Koscik. 1996. Sweat chloride concentrations in infants homozygous and heterozygous for F508 cystic fibrosis. Pediatrics 97:524-528.
7. Gabriel, S. E., K. N. Brigman, B. H. Killer, R. C. Boucher, and M. J. Stutts. 1994. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266:107-109.
8. Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cell. Signal. 13:85-94.
9. Kammouni, W., C. Figarella, S. Marchand, and M. Merten. 1997. Altered cytokine production by cystic fibrosis tracheal gland serous cells. Infect. Immun. 65:5176-5183.
10. Khan, T. Z., J. S. Wagener, T. Bost, J. Martinez, F. J. Accurso, and D. W. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1075-1082.
11. Linevsky, J. K., C. Pothoulakis, S. Keates, M. Warny, A. C. Keates, J. T. LaMont, and C. P. Kelly. 1997. IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes. Am. J. Physiol. 273: G1333-G1340.
12. Massie, R. J., B. Wilcken, P. Van Aseren, S. Dorney, M. Gurca, V. Wiley, and K. Gastrin. 2000. Pancreatic function and extended mutation analysis in delta F508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels. J. Pediatr. 137:214-220.
13. Muhlebach, M. S., P. W. Stewart, M. W. Leigh, and T. L. Noah. 1999. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am. J. Respir. Crit. Care Med. 160:186-191.
14. Noah, T. L., H. R. Black, P. W. Cheng, R. E. Wood, and M. W. Leigh. 1997. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J. Infect. Dis. 175:638-647.
15. Pfeffer, K. D., T. P. Huecksteadt, and J. R. Hoidal. 1993. Expression and regulation of tumor necrosis factor in macrophages from cystic fibrosis patients. Am. J. Respir. Cell Mol. Biol. 9:511-519.
16. Riordan, J. R., J. M. Rommens, B. S. Kerem, N. Alon, R. Rozmahel, Z. Grzelczak, J. Zielenski, S. Lok, N. Plavsic, J. Chou, M. L. Drum, M. C. Iannuzzi, F. S. Collins, and L.-C. Tsui. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073.
17. Sharer, N., M. Schwarz, G. Malone, A. Howarth, J. Painter, M. Super, and J. Braganza. 1998. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N. Engl. J. Med. 339:645-652.
18. Stancovski, I., and D. Baltimore. 1997. NF-κB activation: the IκB kinase revealed? Cell 91:299-302.
19. Tabary, O., S. Escotte, J. P. Couetil, D. Hbert, D. Dusser, E. Puchelle, and J. Jacquot. 1999. Genistein inhibits constitutive and inducible NFκB activation and decreases IL-8 production by cystic bronchial gland cells. Am. J. Pathol. 155:473-481.
20. Tabary, O., S. Escotte, J. P. Couetil, D. Hubert, D. Dusser, E. Puchelle, and J. Jacquot. 2002. Relationship between IkappaBalpha deficiency, NFkappaB activity and interleukin-8 production in CF human airway epithelial cells. Pflugers Arch. 443(Suppl. 1):S40-S44.
21. Tabary, O., J. M. Zahm, J. Hinnrasky, J. P. Couetil, P. Cornillet, M. Guenounou, D. Gaillard, E. Puchelle, and J. Jacquot. 1998. Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am. J. Pathol. 153:921-930.
22. Thomas, G. R., E. A. Costelloe, D. P. Lunn, K. J. Stacey, S. J. Delaney, R. Passey, E. C. McGlinn, B. J. McMorran, A. Ahadizadeh, C. L. Geczy, B. J. Wainwright, and D. A. Hume. 2000. G551D cystic fibrosis mice exhibit abnormal regulation of inflammation in lungs and macrophages. J. Immunol. 164:3870-3877.
23. Tirouvanziam, R., S. de Bentzmann, C. Hubeau, J. Hinnrasky, J. Jacquot, B. Peault, and E. Puchelle. 2000. Inflammation and infection in naive human cystic fibrosis airway grafts. Am. J. Respir. Cell Mol. Biol. 23:121-127.
24. Van Heekeren, A., R. Walenga, M. W. Konstan, T. Bonfield, P. B. Davis, and T. Ferkol. 1997. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J. Clin. Investig. 100:2810-2815.
25. Wang, X., B. Moylan, D. A. Leopold, J. Kim, R. C. Rubenstein, A. Togias, D. Proud, P. L. Zeitlin, and G. R. Cutting. 2000. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 284:1814-1819.
26. Warny, M., A. C. Keates, S. Keates, I. Catagliuolo, J. K. Zacks, S. Aboudola, A. Qamar, C. Pothoulakis, J. T. LaMont, and C. P. Kelly. 2000. p38 MAPK activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J. Clin. Investig. 105:1147-1156.
27. - channel function. Am. J. Physiol. Lung Cell Mol. Physiol. 281:L71-L78.
28. Yoshimura, K., H. Nakamura, B. C. Trapnell, C. S. Chu, W. Dalemans, A. Pavirani, J. P. Lecocq, and R. G. Crystal. 1991. Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids Res. 19:5417-5423.